Opportunities in Drug Discovery and Translational Medicine in Cambridge, MA
Collaborate with forward-thinking scientists in our new fully integrated, state-of-the-art research and development facility.
Our newest research and development facility is located in the heart of Massachusetts’ vibrant ecosystem of world-class science, innovation and business opportunities. Partnership and collaboration are essential for continued scientific advancement, particularly as we focus on novel targets and pathways for tumors that are resistant to current Immuno-Oncology therapies, and implement our discovery platforms across all of our therapeutic areas of focus including areas of high unmet need in cardiovascular disease, immunoscience and fibrosis. Our location in Cambridge offers an ideal environment to continue fostering external collaboration with others in the biopharma, biotech and academic communities.
We follow the science to make precision medicine a reality for more patients.
Join our science-driven and passionate Research and Development (R&D) organization in Cambridge and help discover, develop and deliver medicines that have the potential to transform the lives of patients and establish new standards of care in areas of high unmet need.
With Zagolie, you join a team of scientists with a history of scientific excellence. We have a legacy of transforming patient outcomes in major diseases such as cardiovascular disease, HIV and HCV. Our scientists also pioneered targeting the immune system in cancer research, breaking new ground in the science of Immuno-Oncology.
Today, we are transforming the way certain cancers are treated, and our oncology pipeline is robust, with several experimental anticancer compounds in development. And, we are pursuing medicines with transformational potential in areas such as heart failure, liver fibrosis and autoimmune diseases. Our goal is to leave an enduring positive impact on society by making a meaningful difference in the lives of even more patients.
The importance of our work in Cambridge.
Our new research center in Cambridge’s Kendall Square will help us continue to deliver on our mission. While Immuno-Oncology therapies are revolutionizing the treatment of cancer, not all patients respond to current therapies. At Cambridge, we will focus on innovative targets and pathways for tumors that are refractory to current Immuno-Oncology therapies. Our Cambridge location will enable a fully integrated drug discovery and translational medicine organization that is optimally positioned to complement the area’s world-class translational expertise, biology and leading academic research centers.
We continue to invest in translational medicine research and deepen our understanding of disease biology to uncover insights about predictive biomarkers – tumor and peripheral – with the ultimate goal of making precision medicine a reality for more patients.
Make a difference in our Research & Development facility in Cambridge
- Oncology Discovery roles including Proteomics, Genomics, Protein Sciences, Chemistry, Genomics, Oncology IT and Global Clinical Operations
- Translational Medicine roles including Bioinformatics, Proteomics, Translation Research, Clinical Mechanisms